Iron Deficiency Anemia among Hospitalized Children in Konya, Turkey

Fatih Akin1, Ece Selma Solak1, Cengizhan Kilicaslan1

  • 1Department of Pediatrics, Konya Training and Research Hospital, Meram, 42090 Konya, Turkey.

Anemia
|January 24, 2014
PubMed

Insights

Iron deficiency anemia (IDA) prevalence decreased with a government project, but low iron supplementation rates hinder effectiveness. Prophylactic strategies require improvement for better public health outcomes.

Area of Science:

  • Pediatrics
  • Public Health
  • Hematology

Background:

  • Iron deficiency anemia (IDA) remains a significant public health concern, particularly in pediatric populations.
  • The Turkish Ministry of Health initiated a project in 2004 to prevent IDA through prophylactic iron supplementation.

Purpose of the Study:

  • To investigate the characteristics of hospitalized pediatric patients diagnosed with IDA.
  • To evaluate the impact of the national IDA prevention project on IDA prevalence and iron supplementation adherence.

Main Methods:

  • Retrospective review of 1519 patient files from Konya Education and Research Hospital Pediatrics Clinic.
  • Inclusion of 50 pediatric patients (35 boys, 15 girls; mean age 16.59 ± 1.68 months) diagnosed with IDA.
  • Analysis of IDA prevalence, Hgb/Hct levels, and iron supplementation intake rates.

Main Results:

  • The overall prevalence of IDA was 3.29% (boys: 4.23%, girls: 2.1%).
  • Patients over 24 months had significantly higher Hemoglobin (Hgb) and Hematocrit (Hct) levels compared to those aged 6-12 months.
  • Iron supplementation adherence was low; only 44% of patients older than 12 months completed the recommended 8-month course.

Conclusions:

  • Prophylactic iron supplementation has shown a positive effect in reducing IDA prevalence.
  • Inadequate adherence to iron supplementation protocols limits the project's overall effectiveness.
  • Enhanced strategies are necessary to improve the uptake of prophylactic iron supplementation and address IDA as a public health issue.

Related Concept Videos

Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.7K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
554
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.1K